Updated on 22 April 2013
Mr KV Venugopalan, president, Waters India
Waters India, which celebrated its silver jubilee in 2012, is a key player in the separations segment in the India market. The firm is expanding its headquarter in Bangalore with improved laboratories, upgraded training facilities and more office space.
When completed, the new facility will be spread across approximately 16,000 square feet floor space. Moreover, Waters India plans to focus on other new markets such as vaccines and monoclonal antibodies manufacturing. The firm also plans to expand its their portfolio in various segments such as consumables, informatics products, and liquid chromatography and leverage their established presence with customers. Waters India has become the fastest growing Waters subsidiary in the world. The strength of Waters India lies in the fact that they are particularly focused on the separations segment, which has allowed them to maintain a leadership profile.
Across the country, Waters partners with pharmaceutical companies, contract research organizations (CROs) and government agencies with the goal of expanding research capabilities, increasing laboratory efficiency, and navigating complex regulatory compliance requirements worldwide. Examples of recent partnerships include Dr Reddy's Laboratories, Lambda Therapeutic Research, the Marine and Agricultural Product Export Development Agency and India Environmental Protection Agency. BioSpectrum spoke to Mr KV Venugopalan, president, Waters India, about the future plans of the firm and the opportunities that it sees in India.
Waters has been growing well in India? Where do you see the growth coming in the future?
Waters is the technology leader in five complimentary technologies, including liquid chromatography (LC), mass spectrometry (MS), informatics, columns and consumables and analytical standards. In India we have a strong presence in all segments of markets particularly the highly regulated pharmaceutical industry. Since this segment of the market continues to grow, we expect our business also to follow suit.
There has been some slowing down in the CRO market due to various regulatory issues. Now that such issues are being addressed, we expect the business to catch up in those sectors also. Food safety and environmental market is fast growing in India with mega investments planned by Government of India through FSSAI, we expect a fair share of that opportunity to come in our favor.